Secondary metabolites isolated from Penicillium christenseniae SD.84 and their antimicrobial resistance effects

Nat Prod Res. 2024 Apr;38(8):1311-1319. doi: 10.1080/14786419.2022.2140150. Epub 2022 Nov 6.

Abstract

A pair of new quinolone alkaloid enantiomers, (Ra)-(-)-viridicatol (1) and (Sa)-(+)-viridicatol (4), and seven known compounds, namely, 2, 3 and 5-9, were isolated from Penicillium christenseniae SD.84. The structures of 1 and 4 were determined using NMR and HRESIMS data. Theoretical calculations through CD and ECD confirmed 1 and 4 as a pair of enantiomers. The MIC values of 4 against Staphylococcus aureus and methicillin-resistant S. aureus were 12.4 and 24.7 μM, respectively, compound 1 had no inhibitory activity. Antimicrobial assays of 2, 3, and 5-7 showed a moderate activity against S. aureus and methicillin-resistant S. aureus. This study demonstrated the remarkable potential of Penicillium sp. to produce new drug-resistant leading compounds, thereby advancing the mining for new sources of antimicrobial agents.

Keywords: Penicillium christenseniae SD.84; antimicrobial activity; enantiomer; secondary metabolites; structural elucidation.

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Infective Agents* / metabolism
  • Anti-Infective Agents* / pharmacology
  • Drug Resistance, Bacterial
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Penicillium* / chemistry
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents

Supplementary concepts

  • Penicillium christenseniae